Back
Citizens Financial Group, Inc. (Rhode Island) Vs. Structure Therapeutics, Inc. Industry Stock Comparison
Buy
93
CFG
Citizens Financial Group, Inc. (Rhode Island)
Last Price:
$59.83
Seasonality Move:
-3.82%
Buy
63
GPCR
Structure Therapeutics, Inc.
Last Price:
$69.61
Seasonality Move:
-34.19%
Buy
93
Citizens Financial Group, Inc. (Rhode Island) (CFG)
is a Buy
Is Citizens Financial Group, Inc. (Rhode Island) a Buy, Sell or Hold?
-
The current Citizens Financial Group, Inc. (Rhode Island) [CFG] share price is $59.86. The Score for CFG is 93, which is 86% above its historic median score of 50, and infers lower risk than normal.
-
CFG is currently trading in the 90-100% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR)
is a Buy
Is Structure Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Structure Therapeutics, Inc. [GPCR] share price is $69.69. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CFG Stock Price Chart
What is Citizens Financial Group, Inc. (Rhode Island)'s stock price today?
-
The Citizens Financial Group, Inc. (Rhode Island) share price today is $59.86Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CFG is experiencing buying pressure, which is a positive indicator for future bullish movement.
GPCR Stock Price Chart
What is Structure Therapeutics, Inc.'s stock price today?
-
The Structure Therapeutics, Inc. share price today is $69.69Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight selling pressure.
CFG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.81 | Buy |
| Relative Strength Index (14 RSI): | 74.72 | Buy |
| Chaikin Money Flow: | 611794 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.48 - 58.88) | Buy |
| Bollinger Bands (100): | (49.32 - 55.38) | Buy |
GPCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.55 | Buy |
| Relative Strength Index (14 RSI): | 70.17 | Buy |
| Chaikin Money Flow: | -284110 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.64 - 66.86) | Buy |
| Bollinger Bands (100): | (17.09 - 46.21) | Buy |
CFG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 59.01 | Buy |
| 20-day SMA: | 57.16 | Buy |
| 50-day SMA: | 53.61 | Buy |
| 200-day SMA: | 47.02 | Buy |
| 8-day EMA: | 59 | Buy |
| 20-day EMA: | 57.29 | Buy |
| 50-day EMA: | 54.76 | Buy |
| 200-day EMA: | 49.15 | Buy |
GPCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.76 | Buy |
| 20-day SMA: | 54.7 | Buy |
| 50-day SMA: | 41.07 | Buy |
| 200-day SMA: | 26.34 | Buy |
| 8-day EMA: | 65.27 | Buy |
| 20-day EMA: | 57.2 | Buy |
| 50-day EMA: | 45.22 | Buy |
| 200-day EMA: | 31.64 | Buy |
Citizens Financial Group, Inc. (Rhode Island) Earnings Growth & CFG Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.64 per share, and an increase next year of $1.19 per share.
Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.
Citizens Financial Group, Inc. (Rhode Island) Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Structure Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||